Interleukin-12 in patients with cancer is synthesized by peripheral helper T lymphocytes
- Authors:
- Marcia A. Michelin
- Leticia Montes
- Rosekeila S. Nomelini
- Douglas R. Abdalla
- Andre A. R. Aleixo
- Eddie F. C. Murta
View Affiliations
Affiliations: Oncology Research Institute (IPON), Federal University of Triângulo Mineiro, Uberaba, Minas Gerais 38025‑440, Brazil
- Published online on: July 8, 2015 https://doi.org/10.3892/ol.2015.3470
-
Pages:
1523-1526
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The production of cytokines by helper T lymphocytes is a critical event in the immune response, as alterations in the regulation of this process may result in an appropriate immune response, persistent infection or the development of autoimmune disease. Previously, this group has used flow cytometry to demonstrate the expression of interleukin‑12 (IL-12) in peripheral blood CD4+ T lymphocytes from patients and mice with advanced cancer. The aim of the present study was to investigate whether CD4+ T lymphocytes from the peripheral blood (PB) of patients with cancer produce IL‑12, using molecular approaches, flow cytometry and cellular imaging techniques. CD3+ and CD4+ cells, and cells producing IL‑12, were isolated from the PB obtained from patients with cancer, using a cell sorting flow cytometry technique. The positivity of cells for CD3, CD4 and IL‑12, which were identified by cell sorting, was visualized using immunofluorescent cellular imaging. Total RNA was extracted from the CD3+CD4+IL‑12+ cells, obtained by cell sorting, for confirmation of the presence of IL‑12 mRNA, using reverse transcription‑polymerase chain reaction (RT‑PCR). RT‑PCR demonstrated the presence of IL‑12 mRNA in all patients (n=14), in contrast to the control group, in whom IL‑12 expression was not detected. Immunofluorescent analysis of CD4+ T lymphocytes showed positive intracytoplasmatic IL‑12 staining. These results demonstrated that CD3+CD4+ T lymphocytes in the PB of patients with cancer have the capacity to synthesize and express IL-12.
View References
|
1
|
Mosmann TR and Coffman RL: Th1 and Th2
cells: Different patterns of lymphokine secretion lead to different
functional properties. Annu Rev Immunol. 7:145–173. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Murphy KM and Stockinger B: Effector T
cell plasticity: Flexibility in the face of changing circumstances.
Nat Immunol. 11:674–680. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vignali DA and Kuchroo VK: IL-12 family
cytokines: Immunological playmakers. Nat Immunol. 13:722–728. 2013.
View Article : Google Scholar
|
|
4
|
Wang J, Nong L, Wei Y, Qin S, Zhou Y and
Tang Y: Association of interleukin-12 polymorphisms and serum IL-12
p40 levels with osteosarcoma risk. DNA Cell Biol. 32:605–610. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rodrigues CM, Matias BF, Murta EF and
Michelin MA: The role of T lymphocytes in cancer patients
undergoing immunotherapy with autologous dendritic cells. Clin Med
Insights Oncol. 5:107–115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Michelin MA, Abdalla DR, Aleixo AA and
Murta EF: Peripheral helper lymphocytes produce interleukin 12 in
cancer patients. Clin Med Insights Oncol. 7:75–81. 2013.PubMed/NCBI
|
|
7
|
Tripathy NK, Chauhan SK and Nityanand S:
Cytokine mRNA repertoire of peripheral blood mononuclear cells in
Takayasu's arteritis. Clin Exp Immunol. 138:369–374. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones LL, Chaturvedi V, Uyttenhove C, Van
Snick J and Vignali DA: Distinct subunit pairing criteria within
the heterodimeric IL-12 cytokine family. Mol Immunol. 51:234–244.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lasek W, Zagożdżon R and Jakobisiak M:
Interleukin 12: Still a promising candidate for tumor
immunotherapy? Cancer Immunol Immunother. 63:419–435. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Misson DR, Abdalla DR, Borges AM, Shimba
DS, Adad SJ, Michelin MA and Murta EF: Cytokine serum levels in
patients with cervical intraepithelial neoplasia grade II–III
treated with intralesional interferon-α 2b. Tumori. 97:578–584.
2011.PubMed/NCBI
|
|
11
|
Kerkar SP, Muranski P, Kaiser A, Boni A,
Sanchez-Perez L, Yu Z, Palmer DC, Reger RN, Borman ZA, Zhang L, et
al: Tumor-specific CD8+ T cells expressing IL-12 eradicate
established cancers in lymphodepleted hosts. Cancer Res.
70:6725–6734. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuka M, Munitic I and Ashwell JD:
Identification and characterization of polyclonal αβ T cells with
dendritic cell properties. Nat Commun. 3:12232012. View Article : Google Scholar : PubMed/NCBI
|
